N

Newron Pharmaceuticals
NWRN

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
CHF288.24M
EV
CHF296.99M
Shares Outstanding
20.75M
Beta
0.68
Industry
Biotechnology

Wall Street View

Analyst Rating
BUY
Analyst Target Price
Number of Analysts
3
P/E 2025E
-
P/Revenue 2025E
13.72x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Newron Pharmaceuticals S.p.A.

gainify

N

Newron Pharmaceuticals S.p.A.

NWRN

Newron Pharmaceuticals S.p.A., a biopharmaceutical company, discovers and develops novel therapies for patients with diseases of the central and peripheral nervous system in Italy and the United States. It offers Xadago (safinamide), a chemical entity for the treatmen...

Sector

Healthcare

Industry

Biotechnology

CEO

Weber, Stefan

Employees

22

IPO Date

2006-12-12

Headquarters

Via Antonio Meucci 3, Bresso, Milan, 20091, Italy

gainifypowered-by-sp
Socials
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on TrustpilotFollow us on YouTubeFind us on Google Maps

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.